Xiawei Wei

26.5k citations
272 papers · 20.7k · 20 hit papers · h-index 67

Impact in

  • Immunology top 0.5%
    • Immunotherapy and Immune Responses
    • Immune cells in cancer
  • Oncology top 0.5%
    • Cancer Immunotherapy and Biomarkers
    • Cancer Cells and Metastasis

Papers in

Xiawei Wei

261 papers receiving 20.4k citations

Xiawei Wei's Hit Papers

Cancer vaccines: current status and future directions 2025 · 48 citations
480+1+3Years since publication250500750

Peers

Xiawei Wei
Comparison fields: 5 of 158
  • Immunology 2.7k
  • Oncology 2.9k
  • Biomaterials 1.5k
  • Infectious Diseases 1.8k
  • Molecular Biology 5.5k
Replace Zheng Wang with:
Zheng Wang China
Canhua Huang China
Qianming Chen China
Behzad Baradaran Iran
Jianhua Yu United States
Xuelei Ma China
Abhishek Dinkarnath Garg Belgium
Patrizia Agostinis Belgium
Mehdi Yousefi Iran
Gabriel Lopez‐Berestein United States
Xiawei Wei relative to Zheng Wang China Zheng Wang's profile →
Citations per field
00.5×1.5×2×2.4×
Zheng Wang · 1×
Citations per year

Countries citing papers authored by Xiawei Wei

Since Specialization
Citations

This map shows the geographic impact of Xiawei Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiawei Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiawei Wei more than expected).

Fields of papers citing papers by Xiawei Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiawei Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiawei Wei. The network helps show where Xiawei Wei may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiawei Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiawei Wei Line = papers co-authored together Xiawei Wei links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 272 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Targeting PI3K in cancer: mechanisms and advances in clinical trials
Hit paper breakdown →
20191238
2
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
Hit paper breakdown →
2019827
3
Targeting TGF-β signal transduction for fibrosis and cancer therapy
Hit paper breakdown →
2022814
4
The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis
Hit paper breakdown →
2022700
5 2020624
6
Cancer vaccines as promising immuno-therapeutics: platforms and current progress
Hit paper breakdown →
2022572
7 2020541
8
Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets
Hit paper breakdown →
2022426
9
Cellular Toxicity and Immunological Effects of Carbon-based Nanomaterials
Hit paper breakdown →
2019410
10
AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications
Hit paper breakdown →
2019406
11
SARS‐CoV‐2 Omicron variant: Characteristics and prevention
Hit paper breakdown →
2021403
12
mRNA vaccine: a potential therapeutic strategy
Hit paper breakdown →
2021326
13 2020313
14 2020285
15 2019280
16 2017276
17 2016275
18 2019275
19 2015274
20
Role of the CCL2‐CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting
Hit paper breakdown →
2021273

About Xiawei Wei

Xiawei Wei is a scholar working on Immunology, Infectious Diseases, Oncology, Biomaterials and Molecular Biology, having authored 272 papers that have together received 20.7k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (39 papers), Nanoparticle-Based Drug Delivery (23 papers), Immunotherapy and Immune Responses (23 papers), RNA Interference and Gene Delivery (21 papers), Immune cells in cancer (19 papers), Cancer Immunotherapy and Biomarkers (10 papers), Cancer Cells and Metastasis (9 papers) and Advanced biosensing and bioanalysis techniques (7 papers). The work is most often cited by research in Immunology (2.7k citations), Oncology (2.9k citations), Biomaterials (1.5k citations), Infectious Diseases (1.8k citations) and Molecular Biology (5.5k citations). Xiawei Wei has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yuquan Wei, Manni Wang, Weiqi Hong, Xuelei Ma, Tianxia Lan, Minyang Fu, Yong Peng, Yuhe Huang, Ji Nie and Jing Yang. Their work appears in journals such as Signal Transduction and Targeted Therapy, Journal of Hematology & Oncology, Cell Proliferation, Nature Communications and Molecular Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact